ArticleCureus2025
The United States Preventive Services Task Force (USPSTF) Guidelines vs. Electronic Health Record (EHR)-Based Screening: A Comparative Accuracy Study in Prostate Cancer.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe United States Preventive Services Task Force (USPSTF) provides age-based recommendations for prostate cancer screening. Such a single-criterion strategy can not only miss aggressive cancers that occur before the designated cut-off age, but also over-screen men whose cancers occur at a much older age. A multi-factorial model incorporating a wide spectrum of medical history may offer more accurate predictions. Such cancer prediction models may excel by incorporating diverse medical histories, including causal and non-causal conditions, as well as their chronological relationship with the onset of cancer.
objectiveThis study aims to develop an AI (machine learning)-driven predictive model for prostate cancer based on patients' medical history and compare its performance with traditional age-based criteria.
methodsA predictive model was developed based on electronic health records (EHRs) from the
resultsThe EHR-based model achieved a 10-fold cross-validated McFadden's R² of 0.36, significantly outperforming a model based on USPSTF eligibility criteria, which had an R² of 0.20. Validation using AUROC further demonstrated that the proposed model outperformed current screening criteria in terms of both sensitivity and specificity.
conclusionThis study highlights the potential of personalized screening strategies and demonstrates that AI-driven prediction models based on EHR data can predict prostate cancer with better accuracy than existing age-based guidelines through non-invasive means. Such approaches may help reduce invasive diagnostic procedures due to unnecessary screening and improve early detection by focusing diagnostic efforts on those most at risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.